JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2012, Vol. 50 ›› Issue (9): 91-.

• Articles • Previous Articles     Next Articles

Correlation between  SATB1 and HER2 expressions and
 the tumor grade in breast cancer

WANG Jing-nan1， ZHENG Yan2， XIAO Dong-jie2， LI Jin-xing1，
DING Bu-tong2， LIU Xiang-dong3， WANG Yun-shan2,4   

  1. 1. Department of Laboratory, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250013, China;
    2. Central Laboratory, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, China;
    3. Department of Laboratory, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China;
    4. Medical Research & Laboratory Diagnostic Center, Jinan Central Hospital Affiliated to
    Shandong University, Jinan 250013, China
  • Received:2012-02-10 Online:2012-09-10 Published:2012-09-10

PDF (PC)

636

Abstract:

Objective   To test the expressions of special AT rich sequence binding protein (SATB1) and human epidermal growth factor receptor 2(HER2 ), and to investigate their relationships with the differentiation of breast carcinoma. Methods   Expressions of SATB1 and HER2 were evaluated by  immunohistochemistry method. Fluorescence in situ hybridization(FISH) was used to test the HER2 gene amplification. The association between SATB1 and HER2 expressions and their relationships with the clinicopathologic features of breast carcinoma were analyzed. Results   SATB1 and HER2 were highly expressed in breast carcinoma, and there were a significant correlation between the two(r=0.425, P＜0.05). SATB1 and HER2 expressions were related to the tumor histological grade, and the histological grade of double positive samples was higher. Co-expression of them was significantly correlated with tumor grade Ⅲ in breast cancer(r=0.472, P＜0.05).  Conclusion   SATB1 could regulate the expression of HER2, and SATB1/HER2 positive co-expression might be a poorly differentiated marker in the breast cancer.

Key words: Breast carcinoma; Special AT rich sequence binding protein; Human epidermal growth factor receptor 2; Tumor grade; Poorly differentiated; Fluorescence in situ hybridization

CLC Number: 

  • R737.9
[1] MA Zhen-shen1, WANG Da-wei2, SUN Xiu-bin3, SHI Hao1, PANG Tao1, DONG Gui-qing1, ZHANG Cheng-qi1. Quantitative analysis of 3.0T MR in differential diagnosis of breast lesions [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(9): 79-83.
[2] CHI Wei-wei1, GAO Hai-yan2, GAO Hai-dong3. The molecular mechanism of transforming growth factor-β1-induced transmembrane protein participating in the development of breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(4): 26-29.
[3] LI Shan-shan， SUN Ying, DING Huan, LI Li. β-catenin expressions in different subtypes of breast cancer and its clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 107-110.
[4] CEN Dong-zhi. Overexpression of NRIP3  gene inhibited metastasis in lymph node
negative breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 83-.
[5] ZHANG Jia-xin, MA Zhong-bing, YU Li-xiang, LIU Li-yuan, WANG Fei, GUO Ming-ming, WANG Feng, YU Zhi-gang. Associations between breast cancer and serum
levels of adiponectin and leptin [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(6): 110-.
[6] WAN Yue, CHEN Shou-hua, GU He, ZHANG Li-li. Effects of bortezomib in combination with epirubicin on the
proliferation and apoptosis of breast cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 43-46.
[7] DU Jin-ling1， LIU De-xiang1， CHEN Wen-qiang2， JIANG Hong1， ZHANG Qian1， Pan Fang1. Stress responses and related factors of patients with coronary
heart disease after coronary intervention [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 131-.
[8] WANG Xin-gang1,2， WANG Xiao-feng3， LI Fu-nian2， HOU Lin4， YANG Qi-feng1. Effects of epigenetic drugs on BRCA1 and CHD5 expressions in breast cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(7): 29-34.
[9] GUO Ming-ming， YU Zhi-gang， MA Zhong-bing， GAO De-zong， LI Liang， LI Yu-yang， ZHANG Qiang， WANG Feng， WANG Fei， FU Qin-ye. Microarray-based gene expression profiles related to breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(7): 94-99.
[10] WANG Ze-jun1, XU Cheng-wei1, MA Xiao-li2, ZHENG Yan2, JIA Yan-fei2, XIAO Dong-jie2, WANG Yun-shan2 . Effect of CPB2 gene silencing on TAFI expression and   metastasis in breast cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(4): 57-.
[11] YANG Hua-wei， LIU Jian-lun， JIANG Yi，TANG Wei，WEI Wei ，HUANG Zhen. Expression of lysyl oxidase in breast cancer and its clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(4): 136-140.
[12] WANG Xing-miao1， LI Meng-quan1， WANG Li-juan2， SU Jing1， HU Di1. Expressions of Caspase-3, OPN and Ezrin in invasive ductal  carcinoma of breasts and their clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(4): 141-145.
[13] . Construction of the recombinant plasmid pEGFP-N1-ZIP10 and its effect  on expressions of other zinc transporters in breast cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(11): 29-32.
[14] XU Yue-juan, QIU Shao-min. Expressions of estrogen receptor, progesterone receptor and c-erbB-2and their relationship with prognosis in breast carcinoma tissues [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(9): 100-103.
[15] LIU Yun-cong1, RAN Li2, XIE Fei3, TAN Shi-sheng1, LI Hang1. Expression of BclXl and its relationship with clinical pathology in breast cancer tissues [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(9): 104-106.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd